ThibaultSchulthess

Collaborateur

Paris + 33.1.56.59.46.01

Thibault Schulthess exerce dans le domaine du droit des affaires et plus spécifiquement en matière de droit des sociétés et fusions-acquisitions. Il conseille régulièrement des entreprises françaises et étrangères sur des opérations de fusions, acquisitions, cessions, joint-ventures, restructurations et autres opérations stratégiques, qu'elles soient domestiques ou transfrontalières.

Thibault intervient pour le compte de sociétés et clients industriels dans des secteurs variés (notamment dans les domaines de l'énergie, de la banque, de la santé et de la pharmacie).

Expérience

  • Sanofi sells portfolio of well-established consumer healthcare brands to STADAJones Day advised Sanofi in the sale of a portfolio of 7 well-established consumer healthcare brands across several countries, including Belgium, Germany, Hungary, Spain, the U.K., as well as Nordic countries, to STADA Arzneimittel AG.
  • Orano and XTC New Energy create two JVs dedicated to the production of batteries for electric vehiclesJones Day is advising Orano in the context of the setting-up of two joint-ventures dedicated to the production of critical materials for batteries for electric vehicles, together with Chinese group XTC New Energy.
  • Sanofi sells customer healthcare products to ZentivaJones Day advised Sanofi in the sale of a portfolio of 12 customer healthcare products marketed in Europe to Zentiva K.S, a multinational pharmaceutical company headquartered in Prague, Czech Republic.
  • Sanofi sells portfolio of customer healthcare products to Phoenix LabsJones Day advised Sanofi in the sale of a portfolio of 5 customer healthcare products marketed in the United Kingdom and Ireland to Phoenix Labs, a privately-owned pharmaceutical group headquartered in Dublin, Ireland.
  • Sanofi announces carve-out creating EUROAPI and spin-off of approximately 58% of shares to its shareholdersJones Day advised Sanofi in the carve out creating EUROAPI (a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients) and the listing of this entity on Euronext Paris and the placement of 12% to the French State (through French Tech Souveraineté) for a price of up to €150 million.
  • Hilti Group acquires Fieldwire for approximately $300 millionJones Day advised the Hilti Group in its acquisition of Fieldwire, a San Francisco, California, based construction technology company specialized in construction project management software, for approximately $300 million.